Joseph M McClung1, Timothy J McCord2, Kevin Southerland3, Cameron A Schmidt4, Michael E Padgett2, Terence E Ryan4, Christopher D Kontos5. 1. Department of Physiology, East Carolina University, Brody Medical Center, Greenville, NC; Diabetes and Obesity Institute, East Carolina Heart Institute, Brody Medical Center, Greenville, NC. Electronic address: mcclungj@ecu.edu. 2. Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC. 3. Division of General Surgery, Department of Surgery, Duke University Medical Center, Durham, NC. 4. Department of Physiology, East Carolina University, Brody Medical Center, Greenville, NC; Diabetes and Obesity Institute, East Carolina Heart Institute, Brody Medical Center, Greenville, NC. 5. Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC.
Abstract
OBJECTIVE: The primary preclinical model of peripheral artery disease, which involves acute limb ischemia (ALI), can result in appreciable muscle injury that is attributed to the acuity of the ischemic injury. A less acute model of murine limb ischemia using ameroid constrictors (ACs) has been developed in an attempt to mimic the chronic nature of human disease. However, there is currently little understanding of how genetics influence muscle injury following subacute arterial occlusion in the mouse. METHODS: We investigated the influence of mouse genetics on skeletal muscle tissue survival, blood flow, and vascular density by subjecting two different mouse strains, C57BL/6 (BL6) and BALB/c, to ALI or subacute limb ischemia using single (1AC) or double (2AC) AC placement on the femoral artery. RESULTS: Similar to ALI, the 2AC model resulted in significant tissue necrosis and limb perfusion deficits in genetically susceptible BALB/c but not BL6 mice. In the 1AC model, no outward evidence of tissue necrosis was observed, and there were no differences in limb blood flow between BL6 and BALB/c. However, BALB/c mice displayed significantly greater muscle injury, as evidenced by increased inflammation and myofiber atrophy, despite having no differences in CD31(+) and SMA(+) vascular density and area. BALB/c mice also displayed significantly greater centralized myonuclei, indicating increased muscle regeneration. CONCLUSIONS: The susceptibility of skeletal muscle to ischemia-induced injury is at least partly independent of muscle blood flow and vascular density, consistent with a muscle cell autonomous response that is genetically determined. Further development of preclinical models of peripheral artery disease that more accurately reflect the nature of the human disease may allow more accurate identification of genetic targets for therapeutic intervention.
OBJECTIVE: The primary preclinical model of peripheral artery disease, which involves acute limb ischemia (ALI), can result in appreciable muscle injury that is attributed to the acuity of the ischemic injury. A less acute model of murinelimb ischemia using ameroid constrictors (ACs) has been developed in an attempt to mimic the chronic nature of human disease. However, there is currently little understanding of how genetics influence muscle injury following subacute arterial occlusion in the mouse. METHODS: We investigated the influence of mouse genetics on skeletal muscle tissue survival, blood flow, and vascular density by subjecting two different mouse strains, C57BL/6 (BL6) and BALB/c, to ALI or subacute limb ischemia using single (1AC) or double (2AC) AC placement on the femoral artery. RESULTS: Similar to ALI, the 2AC model resulted in significant tissue necrosis and limb perfusion deficits in genetically susceptible BALB/c but not BL6 mice. In the 1AC model, no outward evidence of tissue necrosis was observed, and there were no differences in limb blood flow between BL6 and BALB/c. However, BALB/c mice displayed significantly greater muscle injury, as evidenced by increased inflammation and myofiber atrophy, despite having no differences in CD31(+) and SMA(+) vascular density and area. BALB/c mice also displayed significantly greater centralized myonuclei, indicating increased muscle regeneration. CONCLUSIONS: The susceptibility of skeletal muscle to ischemia-induced injury is at least partly independent of muscle blood flow and vascular density, consistent with a muscle cell autonomous response that is genetically determined. Further development of preclinical models of peripheral artery disease that more accurately reflect the nature of the human disease may allow more accurate identification of genetic targets for therapeutic intervention.
Authors: Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; M J Whitehouse; Brian H Annex Journal: Lancet Date: 2002-06-15 Impact factor: 79.321
Authors: A Dellavalle; G Maroli; D Covarello; E Azzoni; A Innocenzi; L Perani; S Antonini; R Sambasivan; S Brunelli; S Tajbakhsh; G Cossu Journal: Nat Commun Date: 2011-10-11 Impact factor: 14.919
Authors: Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex Journal: Circulation Date: 2003-09-22 Impact factor: 29.690
Authors: Vincent van Weel; Martine M L Deckers; Jos M Grimbergen; Kees J M van Leuven; JanWillem H P Lardenoye; Reinier O Schlingemann; Geerten P van Nieuw Amerongen; J Hajo van Bockel; Victor W M van Hinsbergh; Paul H A Quax Journal: Circ Res Date: 2004-05-20 Impact factor: 17.367
Authors: Joseph M McClung; Timothy J McCord; Terence E Ryan; Cameron A Schmidt; Tom D Green; Kevin W Southerland; Jessica L Reinardy; Sarah B Mueller; Talaignair N Venkatraman; Christopher D Lascola; Sehoon Keum; Douglas A Marchuk; Espen E Spangenburg; Ayotunde Dokun; Brian H Annex; Christopher D Kontos Journal: Circulation Date: 2017-04-25 Impact factor: 29.690
Authors: Cameron A Schmidt; Terence E Ryan; Chien-Te Lin; Melissa M R Inigo; Tom D Green; Jeffrey J Brault; Espen E Spangenburg; Joseph M McClung Journal: J Vasc Surg Date: 2016-12-23 Impact factor: 4.268
Authors: Antoine J Ribieras; Yulexi Y Ortiz; Yan Li; Carlos T Huerta; Nga Le; Hongwei Shao; Roberto I Vazquez-Padron; Zhao-Jun Liu; Omaida C Velazquez Journal: Front Cardiovasc Med Date: 2022-06-16
Authors: Cameron A Schmidt; Adam J Amorese; Terence E Ryan; Emma J Goldberg; Michael D Tarpey; Thomas D Green; Reema R Karnekar; Dean J Yamaguchi; Espen E Spangenburg; Joseph M McClung Journal: Am J Pathol Date: 2018-02-16 Impact factor: 4.307
Authors: Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung Journal: JCI Insight Date: 2018-11-02
Authors: Jonathan D Newman; MacIntosh G Cornwell; Hua Zhou; Caron Rockman; Adriana Heguy; Yajaira Suarez; Henry S Cheng; Mark W Feinberg; Judith S Hochman; Kelly V Ruggles; Jeffrey S Berger Journal: Arterioscler Thromb Vasc Biol Date: 2021-03-04 Impact factor: 8.311
Authors: Terence E Ryan; Cameron A Schmidt; Thomas D Green; Espen E Spangenburg; P Darrell Neufer; Joseph M McClung Journal: Diabetes Date: 2016-06-09 Impact factor: 9.461